topic0
Tumour NOS [neop] 0.00237570276473
HCV [virs] 0.00361669551041
Multicentric [spco] 0.00272597381318
Area [geoa] 0.0034153595821
Survival [acty] 0.00319819840657
liver resection [topp] 0.00295812726687
resection [topp] 0.00643014142386
Based [ftcn] 0.00238843344187
HEPATITIS C VIRUS [virs] 0.00711546553939
Important [qlco] 0.00302687710602
Nodules [acab] 0.00374856164126
Hepatic [blor] 0.00484677424428
Screening [hlca] 0.00267627074681
Performed [ftcn] 0.00261035932569
etiology [ftcn] 0.00245951830859
Suggest [idcn] 0.0027827913854
Study [mnob] 0.00585347003614
Mortality [qnco] 0.00266057566747
HIGH RISK [qlco] 0.00270281715145
Conclusions [idcn] 0.00333879403872
Seroconversion [npop] 0.00242480262736
Methods [inpr] 0.0045577105219
Enhanced [acty] 0.0027458167191
Compared [acty] 0.00382414616429
Hepatitis C virus infection [dsyn] 0.00345457261738
Cases [ftcn] 0.00994184002913
Intrahepatic Cholangiocarcinoma [neop] 0.00447311463036
YEARS [tmco] 0.00533964651282
Contrast [irda] 0.00278796473565
Human [humn] 0.00296006852219
YEAR [tmco] 0.00327426885574
LIVER [bpoc] 0.00939848435662
Identified [qlco] 0.00275188805328
treatment [ftcn] 0.00334605540354
CIRRHOSIS [dsyn] 0.00309262669537
Cirrhotic [qlco] 0.00300148148369
Risk Factors [qnco] 0.00794967045684
Pathology [bmod] 0.00569306137938
Tumors [neop] 0.00430570987372
Biliary [ftcn] 0.00241052912297
topic1
Tumour NOS [neop] 0.00725363568511
LIVER CIRRHOSIS [dsyn] 0.00303992180834
Treated [ftcn] 0.00300761979442
Median [spco] 0.00265072156662
Survival [acty] 0.0046370056007
Group [idcn] 0.00923754795985
resection [topp] 0.00353253907116
HEPATITIS C VIRUS [virs] 0.00367242386483
Hepatic [blor] 0.00282424999634
LIVER [bpoc] 0.00705518124949
HEPATITIS B VIRUS [virs] 0.00287325373063
Long Term [tmco] 0.00257154211354
Observed [ftcn] 0.0025562190128
Independent [idcn] 0.00342718624987
Invasion [fndg] 0.00405924163953
Study [mnob] 0.013503707959
Mortality [qnco] 0.00594380787513
Suggest [idcn] 0.00280243381587
Conclusions [idcn] 0.00502873196915
Methods [inpr] 0.00528212328822
Risk Factors [qnco] 0.00997661788302
Cases [ftcn] 0.00571792674098
Intrahepatic Cholangiocarcinoma [neop] 0.00328820652155
YEARS [tmco] 0.00946168428152
control [qlco] 0.00292721635779
therapy [ftcn] 0.0048318722674
Liver Transplantation [topp] 0.00508161565207
YEAR [tmco] 0.00373810447228
Hepatectomy [topp] 0.00414589312051
Chronic hepatitis C [dsyn] 0.00322264239182
Related [qlco] 0.00421467108791
Postoperative [tmco] 0.00377702596217
Identified [qlco] 0.00257890006928
Odds Ratio [qnco] 0.00290411467412
treatment [ftcn] 0.00647585613351
CIRRHOSIS [dsyn] 0.00438355364652
Levels [qlco] 0.00243541558283
Compared [acty] 0.00496655183985
Pathology [bmod] 0.00274562751273
Tumors [neop] 0.00309424530407
topic2
Tumour NOS [neop] 0.00457894947373
HCV [virs] 0.00241692019276
Compared [acty] 0.00311325653732
Present [qnco] 0.00243679170466
Survival [acty] 0.00763455858624
Group [idcn] 0.00235970447237
resection [topp] 0.00837204629025
Including [ftcn] 0.00354172951119
HEPATITIS C VIRUS [virs] 0.00435762928137
Hepatic [blor] 0.00415587303199
Screening [hlca] 0.00312224858467
Children [aggp] 0.00265704310096
HEPATITIS B VIRUS [virs] 0.00304495339192
Diabetes [dsyn] 0.00502664052007
DIAGNOSIS [fndg] 0.00341312202116
Study [mnob] 0.0060434832316
Independent [idcn] 0.00277800220472
Conclusions [idcn] 0.00256073653244
Methods [inpr] 0.00385880917582
CANCER [neop] 0.00366740805637
Cases [ftcn] 0.00401522767382
CT [geoa] 0.00354777500156
YEARS [tmco] 0.00772651945435
Molecular [qlco] 0.00239910983324
HEPATITIS B [dsyn] 0.00268372149344
Cholangiocarcinoma [neop] 0.00286987205486
YEAR [tmco] 0.0052640719836
LIVER [bpoc] 0.00226203352734
Related [qlco] 0.00488278061906
Hepatitis C [dsyn] 0.00364280570601
Identified [qlco] 0.00236921049726
Odds Ratio [qnco] 0.00319562878477
treatment [ftcn] 0.00641309290972
CIRRHOSIS [dsyn] 0.0053667455162
Complications [patf] 0.00327584621083
Risk Factors [qnco] 0.0163716929788
Pathology [bmod] 0.00391110017992
Tumors [neop] 0.0032593282608
Increased [qnco] 0.00348622310858
HCC [neop] 0.00305298569651
topic3
Tumour NOS [neop] 0.00335574659737
Radiofrequency Ablation [topp] 0.00603212599288
Higher [qlco] 0.00306168349458
Mechanisms [ftcn] 0.00238985639504
Survival [acty] 0.00556197973837
Group [idcn] 0.00319935907544
resection [topp] 0.00439179874819
Including [ftcn] 0.00247889032948
HEPATITIS C VIRUS [virs] 0.00755863338854
lesions [fndg] 0.00258837588702
Hepatic [blor] 0.00884164177267
Steatosis [patf] 0.00332896121905
Hepatectomy [topp] 0.00312136195403
Performed [ftcn] 0.00244305390472
HEPATITIS B VIRUS [virs] 0.00615914018763
Invasion [fndg] 0.00708695438417
Study [mnob] 0.00526234545723
Mortality [qnco] 0.00292074273637
LIVER CIRRHOSIS [dsyn] 0.00286120623313
Methods [inpr] 0.00464532658251
Risk Factors [qnco] 0.00559602585643
Cases [ftcn] 0.00817524932378
YEARS [tmco] 0.00644698419491
Cholangiocarcinoma [neop] 0.00282415456248
YEAR [tmco] 0.00412510344868
LIVER [bpoc] 0.00778234950793
Conclusions [idcn] 0.00261992482183
Related [qlco] 0.00430962243338
Postoperative [tmco] 0.00265217857517
Groups [idcn] 0.00232986093692
Progression [patf] 0.00297179978673
treatment [ftcn] 0.00595221671946
CIRRHOSIS [dsyn] 0.00819913754007
Complications [patf] 0.00233326651581
Cirrhotic [qlco] 0.00242010784168
Reserve [acty] 0.00367519498582
Compared [acty] 0.00422633886304
Pathology [bmod] 0.00249294917248
TIME [tmco] 0.00418383400362
Increased [qnco] 0.00444726913695
topic4
Tumour NOS [neop] 0.0047138969207
Sustained [ftcn] 0.00261587671556
Suggest [idcn] 0.00270020948727
DIAGNOSIS [fndg] 0.00345126604218
Complications [patf] 0.00355293001931
resection [topp] 0.00529082580956
HEPATITIS C VIRUS [virs] 0.00558237930114
Correlated [qlco] 0.00238434699645
Hepatic [blor] 0.00419842691089
Human Immunodeficiency Virus [virs] 0.00252709932682
HEPATITIS B VIRUS [virs] 0.00430930886899
Independent [idcn] 0.00346157074919
Study [mnob] 0.00640645256827
Mortality [qnco] 0.00253369601419
Response [orga] 0.00445570285523
Chronic hepatitis C [dsyn] 0.00359986788883
Nonalcoholic Fatty Liver Disease [dsyn] 0.00453860581749
Methods [inpr] 0.00478265320801
METABOLIC SYNDROME [dsyn] 0.00260003559782
CANCER [neop] 0.00311066420446
Enhanced [acty] 0.00255819102169
Cases [ftcn] 0.00325793454575
YEARS [tmco] 0.00512012647743
Contrast [irda] 0.00428110810408
therapy [ftcn] 0.002661215281
YEAR [tmco] 0.00436658320246
LIVER [bpoc] 0.0101603656472
Conclusions [idcn] 0.00267684076066
Related [qlco] 0.00548176026845
Tumors [neop] 0.00333701548591
Identified [qlco] 0.00239375827589
treatment [ftcn] 0.0097401087046
CIRRHOSIS [dsyn] 0.00519116928994
Survival [acty] 0.00408800992845
FIBROSIS [patf] 0.00238398420279
Risk Factors [qnco] 0.00702478069476
Pathology [bmod] 0.00277587117668
Extrahepatic [spco] 0.00232625781201
TIME [tmco] 0.0036499153807
Increased [qnco] 0.00309271389717
topic5
Tumour NOS [neop] 0.0031786203201
HCV [virs] 0.00250253256936
Radiofrequency Ablation [topp] 0.00285394777251
Higher [qlco] 0.00212449079239
Ultrasonography [diap] 0.00344601052726
Groups [idcn] 0.00247513024835
Survival [acty] 0.00309811484882
Group [idcn] 0.00365624658988
resection [topp] 0.00643363960659
SMOKING [inbe] 0.00211282923278
Based [ftcn] 0.00231811689645
Association [menp] 0.00251336866724
HEPATITIS C VIRUS [virs] 0.00430508425349
Screening [hlca] 0.00477670068054
LIVER [bpoc] 0.00576492670797
Performed [ftcn] 0.00220836809186
HEPATITIS B VIRUS [virs] 0.00212045592942
Suggest [idcn] 0.00315923891724
Study [mnob] 0.00661447413024
Mortality [qnco] 0.00305457474143
DIAGNOSIS [fndg] 0.00369509263757
Conclusions [idcn] 0.00262347773232
Methods [inpr] 0.00525478212634
Compared [acty] 0.00271247395079
Cases [ftcn] 0.00410383491601
Treated [ftcn] 0.00224772011725
Human [humn] 0.00432399162941
Cholangiocarcinoma [neop] 0.00389391892065
CANCER [neop] 0.0025852517023
YEAR [tmco] 0.00325888864313
Hepatectomy [topp] 0.00332577455657
Chronic hepatitis C [dsyn] 0.00229397106545
Related [qlco] 0.00225742875659
treatment [ftcn] 0.00686923389044
CIRRHOSIS [dsyn] 0.00592228978468
Detected [fndg] 0.00321417232158
Risk Factors [qnco] 0.00384855373421
Pathology [bmod] 0.00347026987138
Tumors [neop] 0.00324123975165
Increased [qnco] 0.00271708767304
topic6
Tumour NOS [neop] 0.00498140118018
Sustained [ftcn] 0.00295825902372
Treated [ftcn] 0.00272291006368
Higher [qlco] 0.0035143432994
Groups [idcn] 0.00351957768825
Survival [acty] 0.00789968110353
Group [idcn] 0.00591901395714
resection [topp] 0.0130067138643
Phase [tmco] 0.00278575248533
HEPATITIS C VIRUS [virs] 0.00329554241694
ACUTE RENAL FAILURE [dsyn] 0.00306670787288
Hepatic [blor] 0.00689023074163
Performed [ftcn] 0.00411983699776
HEPATITIS B VIRUS [virs] 0.00774198236071
LIVER DISEASE [dsyn] 0.00252890719028
Invasion [fndg] 0.00299599547603
Study [mnob] 0.00830562536849
LOWER [spco] 0.00245035610422
Conclusions [idcn] 0.00420787101895
Low [qlco] 0.00258741943017
Nonalcoholic Fatty Liver Disease [dsyn] 0.00453265476188
Methods [inpr] 0.00574319744225
Enhanced [acty] 0.00307552484872
Risk Factors [qnco] 0.0142773435206
Hepatitis C virus infection [dsyn] 0.00423351611811
Chemotherapy [topp] 0.00260883752361
Cases [ftcn] 0.00401875197603
YEARS [tmco] 0.00632176454842
Intrahepatic [spco] 0.00289980791629
therapy [ftcn] 0.00375506037946
YEAR [tmco] 0.00505725873858
LIVER [bpoc] 0.0042393327928
Postoperative [tmco] 0.00278573647192
Odds Ratio [qnco] 0.0043683844052
treatment [ftcn] 0.00574484891793
CIRRHOSIS [dsyn] 0.0055624560814
Detected [fndg] 0.00250211812768
Compared [acty] 0.00410048767383
Increased [qnco] 0.0033001587983
Transarterial Chemoembolization [topp] 0.00270827355125
topic7
Early Recurrence [fndg] 0.00364352966014
Tumour NOS [neop] 0.00807584227241
HCV [virs] 0.00328887714717
Treated [ftcn] 0.00352820821963
Groups [idcn] 0.00370359856626
Survival [acty] 0.0134610516313
Group [idcn] 0.00728700484085
resection [topp] 0.00599287047401
DIABETES MELLITUS [dsyn] 0.00220675391214
Including [ftcn] 0.00242287171914
HEPATITIS C VIRUS [virs] 0.00269624526881
Intrahepatic [spco] 0.0062919951438
Nonalcoholic Steatohepatitis [dsyn] 0.00288891699367
Hepatic [blor] 0.00570249455649
LIVER [bpoc] 0.00927135479224
Performed [ftcn] 0.00339768739612
Independent [idcn] 0.00364987907973
Prognostic Factor [clna] 0.00304484944782
Study [mnob] 0.00619360501251
included [ftcn] 0.0024374420549
Conclusions [idcn] 0.00484450645751
Methods [inpr] 0.00541111547836
Risk Factors [qnco] 0.00671190493727
Cases [ftcn] 0.00263907561258
Radiofrequency Ablation [topp] 0.00302716640385
YEARS [tmco] 0.006970296132
Ki-67 [lbpr] 0.00216923939281
Recipient [humn] 0.00226007166264
therapy [ftcn] 0.003393715858
YEAR [tmco] 0.00705517341653
Hepatectomy [topp] 0.00381119138981
Related [qlco] 0.00393196362447
Percutaneous [spco] 0.00271698729984
treatment [ftcn] 0.00519980104925
CIRRHOSIS [dsyn] 0.00733327224539
Increased [qnco] 0.00234169427664
Levels [qlco] 0.00234288602566
Compared [acty] 0.00496951948697
Tumors [neop] 0.0041582117022
Single [popg] 0.00259159344699
topic8
Tumour NOS [neop] 0.00453373713807
MULTIPLE [qnco] 0.00224624544636
Based [ftcn] 0.00242165869547
Group [idcn] 0.00429853743289
Including [ftcn] 0.00403949111091
HEPATITIS C VIRUS [virs] 0.00779840875591
lesions [fndg] 0.00246576405143
Hepatic [blor] 0.00369215827316
Hepatectomy [topp] 0.00505806379214
BENIGN [qlco] 0.00366768186881
HEPATITIS B VIRUS [virs] 0.0037363460112
Observed [ftcn] 0.00256884428466
DIAGNOSIS [fndg] 0.00292147074107
Study [mnob] 0.00424230826434
Mortality [qnco] 0.00225579889026
LIVER DISEASE [dsyn] 0.00269495795618
Conclusions [idcn] 0.00331171719507
Nonalcoholic Fatty Liver Disease [dsyn] 0.0052291682907
Methods [inpr] 0.00445161022192
Compared [acty] 0.00261551174032
Cases [ftcn] 0.00434967561584
YEARS [tmco] 0.00500016163403
Autoimmune Hepatitis [dsyn] 0.00251112340786
UNITED STATES [geoa] 0.00218963574978
YEAR [tmco] 0.00258303102217
LIVER [bpoc] 0.010073741112
LIVER CIRRHOSIS [dsyn] 0.00280180353985
Related [qlco] 0.0036996648817
Focal Nodular Hyperplasia [dsyn] 0.00228481131431
Postoperative [tmco] 0.00261856101212
treatment [ftcn] 0.00273906921095
CIRRHOSIS [dsyn] 0.00426978329558
MALIGNANT [qlco] 0.00327182027147
FIBROSIS [patf] 0.00258567233854
Risk Factors [qnco] 0.00790819360588
Pathology [bmod] 0.00414694471569
JAPAN [geoa] 0.00261000002307
Estimated [qnco] 0.00255083669225
Increased [qnco] 0.00348430909875
Independent [idcn] 0.00267441063372
topic9
Tumour NOS [neop] 0.00491415997141
HCV [virs] 0.00560099292296
HIV [virs] 0.0025126723821
Radiofrequency Ablation [topp] 0.00627967195351
Median [spco] 0.0028845955438
Survival [acty] 0.00321098165933
Group [idcn] 0.00314729260676
Including [ftcn] 0.00306455628288
HEPATITIS C VIRUS [virs] 0.0054520005102
findings [ftcn] 0.0030235641526
lesions [fndg] 0.00850266995359
Nodules [acab] 0.00381684108822
BENIGN [qlco] 0.00300976107429
SERUM [bdsu] 0.00263456339708
DIAGNOSIS [fndg] 0.00273743493112
Imaging [diap] 0.00261598850556
Study [mnob] 0.00338550811935
included [ftcn] 0.00243840506824
Independent [idcn] 0.00240152089027
LIVER CIRRHOSIS [dsyn] 0.00241607915799
Nonalcoholic Fatty Liver Disease [dsyn] 0.0023039734649
Methods [inpr] 0.00521170462302
Hepatitis C virus infection [dsyn] 0.00419160024674
Cases [ftcn] 0.0100173088264
YEARS [tmco] 0.00555263357667
Higher [qlco] 0.0022653195087
therapy [ftcn] 0.00310713240163
YEAR [tmco] 0.00269495803866
LIVER [bpoc] 0.00852158727816
Related [qlco] 0.00240188320794
Hepatitis C [dsyn] 0.00225606781866
Range [qnco] 0.00278970247188
Percutaneous [spco] 0.00285762260121
treatment [ftcn] 0.00410318224821
CIRRHOSIS [dsyn] 0.00266661278991
MALIGNANT [qlco] 0.00278572451458
Risk Factors [qnco] 0.00430974209017
Pathology [bmod] 0.00364443536282
Tumors [neop] 0.00355578122283
Increased [qnco] 0.00240921524852
